How are interleukin-6 receptor antagonists shaping the future of neuromyelitis optica spectrum disorder?
Summary
How are interleukin-6 receptor antagonists shaping the future of neuromyelitis optica spectrum disorder?
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.